Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023
12:39pm, Friday, 30'th Jun 2023
Pharmaceutical stocks have not shared in this year's bull rally. Year to date, the S&P Pharmaceuticals Select Industry index is down 1% while the benchmark S&P 500 index has gained 15%.
3 Dividend Kings Yielding Royal Sums
06:54pm, Thursday, 29'th Jun 2023
If you are focused on investing for income look no further. Dividend Kings are stocks that have raised their dividends for at least 50 consecutive years, a feat made possible by uber-consistent busine
AbbVie president given added COO duties
05:38pm, Thursday, 29'th Jun 2023
AbbVie Inc. ABBV, +0.54% said late Thursday its vice chairman and president will take on the added role of chief operating officer, according to a filing with the Securities and Exchange Commission. T
July Dividend Kings: 5 Buys, 4 To Watch
03:35pm, Thursday, 29'th Jun 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the
5 High-Yielding Dividend Stocks That Are Bargain Buys
10:00am, Thursday, 29'th Jun 2023
Some of the biggest names in healthcare are on sale right now. J&J, AbbVie, Bristol Myers, Amgen, and Pfizer all trade at low valuations.
What Will AbbVie Buy Next?
08:30am, Wednesday, 28'th Jun 2023
AbbVie may be an active player on the merger and acquisition scene in 2023. Blueprint Medicines and Krystal Biotech are two budget-friendly targets.
7 Stocks That Every 40-Year-Old Should Buy Today
08:52pm, Tuesday, 27'th Jun 2023
While swinging for the fences brings excitement to the art of investing, slow and steady usually wins the race, which brings us to the best investments for 40-year-olds. Around this time frame, the em
AbbVie (ABBV) Gets CHMP Positive Opinion for Atogepant Approval
12:46pm, Monday, 26'th Jun 2023
AbbVie (ABBV) receives a positive recommendation from the European Union's medicinal products committee for the approval of its migraine treatment candidate, atogepant.
1 Phenomenal High-Yield Dividend Stock You Can Buy and Hold Forever
05:55am, Sunday, 25'th Jun 2023
This stock is a Dividend King with a juicy dividend yield. It faces some near-term headwinds, but they should only be temporary.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:21am, Thursday, 22'nd Jun 2023
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 No-Brainer Healthcare Stocks to Buy Right Now
08:00am, Thursday, 22'nd Jun 2023
AbbVie's shares are dropping due to an anticipated obstacle, but the company's prospects remain bright. Veeva Systems' deep moat and excellent growth prospects make it a solid stock to buy today.
2 Buffett-Style Blue-Chip Buys For What's Coming Next
07:15am, Wednesday, 21'st Jun 2023
The market rally is unjustified by deteriorating economic fundamentals and $300 billion per month in reverse money printing. A recession is still likely, and current earnings expectations are wildly o
Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo
02:40pm, Tuesday, 20'th Jun 2023
While the smaller-capitalization trades tend to attract the most speculative attention, for reliable upside prospects, investors may want to consider blue-chip stocks to buy. To better understand the
Dividend Income Update May 2023
09:00pm, Monday, 19'th Jun 2023
Without rehashing the wild ride we experienced in the market so far in 2023, I could find comfort in one thing, my dividends. Hitting the elusive four-digit mark in May has been a welcome sign for me
Unlock the Potential of These 7 Cash-Flow Machines
05:45pm, Sunday, 18'th Jun 2023
There are several reasons to seek out high-cash-flow stocks. In the simplest terms, companies that generate strong cash flow can pay – and increase – dividends, develop new products and buy back s
